No specific TNF-α antagonist drugs showed significant associations with TB risk, suggesting that RA patients may face higher risk due to disease-specific immune factors and the use of additional immunosuppressive therapies like corticosteroids. The gene discussed is TNF; the disease is rheumatoid arthritis.